Jiangsu Hengrui reported CNY2.85B in EBIT for its fiscal quarter ending in September of 2026.





Ebit Change Date
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Kangmei Pharma CNY -35.26M 22.54M Jun/2026
Sh Fosun Pharma CNY 863.03M 301.08M Sep/2026
Sh Pharmaceutical CNY 2.77B 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Wuxi Apptec CNY 7.44B 390.43M Sep/2026
Zz Pientze Pharmaceu CNY 362.83M 474.98M Jun/2026